Journal
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY
Volume 6, Issue 5, Pages 543-554Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1517/17425251003614766
Keywords
-
Funding
- Fondo de Investigaciones Sanitarias [06/0621]
- Program 'Ramon y Cajal' of Spanish Ministry
- PN I+D SAF [2005-00855]
- NIH [AT-1576]
- HEPADIP consortium [HEPADIP-EULSHM-CT-205]
- BBVA foundation
- Health Spanish Ministry
- National Center for Complementary & Integrative Health [R01AT001576] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Areas covered in this review: A systematic bibliographic search focused on two related aspects: i) xenobiotic-metabolizing enzymes that have been detected in microvesicles (MVs); and ii) MVs that are in the blood stream or secreted by cell types with clear interactions with this fluid. What the reader will gain: A discussion of these hepatocyte-secreted vesicles along with other MVs as enzymatic carriers in the context of extrahepatic drug-metabolizing systems. Take home message: The contribution of many tissues including the liver to the MV plasma population is supported by several reports. On the other hand, many enzymes involved in the metabolism of drugs have been detected in MVs. Together, these observations support a role of hepatic-MVs in spreading the liver metabolizing activities through the body contributing in this manner to extrahepatic drug metabolism systems what could be relevant for body homeostasis and pharmaceutical interests.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available